oral therapy with Gilead's widely used Truvada (emtricitabine and tenofovir disoproxil fumarate) in a head-to-head trial. The FDA said that PrEP – used to protect at-risk people such as an HIV ...

The therapeutic area has formed a backbone of sales for the company for years, with its first treatment in the area, Viread (tenofovir disoproxil fumarate), approved by the FDA in 2001.

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

[1] Tenofovir disoproxil fumarate (Viread, Gilead Sciences, Inc.) is a new addition to the antiretroviral armamentarium. It is an ester-derived prodrug that is converted in vivo by serum and ...